Pseudohypopyon following intravitreal triamcinolone acetonide injection

Cornea. 2004 May;23(4):398-9. doi: 10.1097/00003226-200405000-00016.

Abstract

Objective: To report a case of a pseudohypopyon that developed after intravitreal injection of triamcinolone acetonide for choroidal neovascularization from age-related macular degeneration.

Methods: Observational case report.

Results: A 62-year-old woman received an intravitreal injection of triamcinolone acetonide for the treatment of a choroidal neovascular membrane that developed as a result of age-related macular degeneration. A layer of yellowish deposits was observed in the anterior chamber 1 day after the injection. The patient denied any pain or reduced vision, and there was no redness noted on examination. The deposits cleared spontaneously on the fourth postoperative day.

Conclusions: Pseudohypopyon may develop after intravitreal injection of triamcinolone acetonide. Distinguishing this from a true hypopyon is important because the treatment and prognosis are very different for the two conditions.

Publication types

  • Case Reports

MeSH terms

  • Anterior Eye Segment / drug effects*
  • Anterior Eye Segment / physiopathology
  • Choroidal Neovascularization / drug therapy
  • Endophthalmitis / chemically induced*
  • Endophthalmitis / physiopathology
  • Female
  • Glucocorticoids / adverse effects*
  • Humans
  • Injections
  • Middle Aged
  • Remission, Spontaneous
  • Triamcinolone Acetonide / adverse effects*
  • Vitreous Body / drug effects*

Substances

  • Glucocorticoids
  • Triamcinolone Acetonide